Following Tuhu Car’s public debut on HKEX, Cathay Innovation’s team in China digs into the Tuhu journey, from startup to IPO… […]
Startup to IPO: How Tuhu Car Became China’s 1st Automotive Aftermarket Company to Debut on the HKEX
Category: Blog
Behind the Term Sheet: How Ghost is Revolutionizing Inventory Management with Access to Excess
Go behind the term sheet of Ghost’s $30M Series B with Simon Wu & Brian Schwarzbach… […]
Global AI Regulation: The Need for Speed in an Era of Unbridled Innovation
The AI revolution is here, but our regulatory bodies are still stuck in the Industrial Age… […]
Data Unleashed: Navigating the Brave New World of Consumer Data
Key Takeaways from Pernod Ricard, Fetch, Tiffany & Co. & Walmart… […]
A New Intelligence Infrastructure: Where AI, Web3 & Cybersecurity Converge
While Web3 is widely known for its promise in decentralization & transparency, Cathay’s Denis Barrier explores how it could also be the highway for a safer AI revolution… […]
Policy: The Least Spoken About, But Most Important Topic in Artificial Intelligence
Cathay Partner Rajive Keshup digs into the multifaceted nature of AI technologies, their impact on society and the compelling reasons why we need thoughtful and balanced regulations in place… […]
Reality vs. Hype: How AI & Human Activity Combine
AI-driven startups across the world weigh in on the impact of the AI revolution on businesses & industries […]
Industry Insights: How Will AI Impact the Modern-Day Education System?
Cathay’s SEA-based Partner Rajive Keshup weighs in on the VC-parent perspective on the potential & limitations of AI in educating the next generations… […]
Reduce, Reuse…Recommerce? Why Recommerce is the New Black
Cathay’s SF-based investor Brian Schwarzbach digs into what’s driving the recommerce resurgence, top areas drawing VC investment and tips for founders building in the space… […]
Behind the Term Sheet: How Inato is Solving the Massive Clinical Trial Access & Diversity Gap
Clinical trials are essential to medical innovation and the development of potentially life-saving drugs. But today, access is wildly off balance… […]